Director, Innovation & Strategy - 2642

FloodGate Medical; Paramus (NJ); On-site; USD 180,000 - 260,000; Full time

Job summary

Regenity Biosciences, a PE-backed leader in regenerative biomaterials, is creating a brand-new function aimed at shaping early-stage technology decisions. This role places you at the center of strategic evaluation and portfolio direction, not merely executing directives.

You will be mentored by a 25-year Regenity veteran recently elevated to the C-suite, gaining exposure to next‑gen platforms such as soluble collagen, new polymers, hyaluronic acid, and cell therapy enablers.

Qualifications

• 8+ years of total career experience in technical or scientific roles.
• Technical or science-based background in engineering or life sciences.
• Experience in medical devices or biomaterials is a strong plus.
• Ability to judge whether a technology is worth pursuing rather than simply executing.
• Comfort working with ambiguity as the role is being built in real time.

Responsibilities

• Shape a brand-new function reporting directly to the Chief Innovation & Strategy Officer.
• Decide whether new technology is worth pursuing and align with strategic goals.
• Receive mentorship from Regenity's 25-year veteran recently elevated to the C-suite.
• Operate within a PE-backed platform and influence product strategy and portfolio direction.
• Work on next‑generation biomaterial platforms that will define Regenity's roadmap.

Skills

Product development

Portfolio management

Upstream marketing

Biomedical knowledge

Technology evaluation

Ambiguity handling

Job description

Regenity Biosciences is a PE-backed (Linden Capital Partners, Cinven) leader in regenerative biomaterials - collagen, bioceramics, and synthetic polymers transformed into bioabsorbable implants 80+ product lines across wound care, sports medicine, spine/ortho, dental, dural repair, ENT, and cardiovascular, serving 125+ customers including Stryker, J&J MedTech, Medtronic, and Smith+Naphew #1 or #2 market position in Sports Medicine, ENT, Dental, Dural, and Peripheral Nerve categories Backed by 28 years of collagen R&D and 27 years of polymer R&D, with 138 patents issued and 48 pending $2.7B addressable market today, growing to $4.9B by 2030, including new frontiers in drug delivery and drug-device combinations

A rare, ground-floor opportunity to shape a brand-new function reporting directly to the Chief Innovation & Strategy Officer

Real influence: you'll be the person the business defers to on whether new technology is worth chasing; not just executing decisions made elsewhere

Direct mentorship from a 25-year Regenity veteran recently elevated into a newly created C-suite role

Work at the center of a growing, PE-backed platform with real momentum, without the bureaucracy of a much larger organization

A seat inside the exact next-generation platforms (soluble collagen, new polymers, hyaluronic acid, cell therapy enablers) that will define where the company goes next

A technical or science-based background (engineering, life sciences, or similar) ; you don't need to be a career dealmaker, but you do need to be able to judge whether a technology is actually worth pursuing

Experience in medical devices; specific biomaterials exposure is a strong plus but not required

Comfortable operating with real ambiguity - this is a role being built in real time, not one with an established playbook

Around 8+ years of total career experience, ideally including some product development, portfolio management, or upstream marketing along the way

High energy, genuinely curious, and quick to find a path forward rather than a reason something can't be done